Welcome To Campus Sanofi Thailand

Curated June evidence on atopic dermatitis, organised around the four disease-modification pillars — starting with new data on skin-barrier restoration in children

I am pleased to share information regarding the Biologics in Atopic Dermatitis: Effectiveness, Safety, and Future Directions, which you may find of interest. In this email, you will find the key highlights on dupilumab for long-term disease management in atopic dermatitis.

Explore ATS 2026 key sessions on dupilumab, COPD biologics, FeNO biomarkers, and asthma remission. Real-world evidence for HCPs

SCORE-AD Calculator & Atopic Dermatitis Assessment Tools for Healthcare Professionals. Access validated severity scales including SCORAD, EASI, vIGA-AD, DLQI, and POEM to evaluate disease severity, patient outcomes, and quality of life in one platform.

แนวทางกำกับการเบิกจ่ายค่ายา Dupilumab ข้อบ่งใช้ โรคผื่นภูมิแพ้ผิวหนัง (Atopic dermatitis) สำหรับผู้ป่วยเด็กที่มีอายุตั้งแต่ 6 เดือน ถึง 12 ปี

แนวทางการจ่ายยา dupilumab ในรักษาโรคหืดรุนแรง

The United in Rare: Advancing LSDs Care across Asia event was held on the 22^nd to 23^rd November 2025 in Bangkok, Thailand. The event aimed to provide a platform for experts across Thailand, Malaysia, Singapore, Taiwan, South Korea and India to share their experiences in management of LSDs by discussing challenges cases and best practices to improve diagnosis and treatment pathways for LSDs.